EMAIL THIS PAGE TO A FRIEND

Pediatric endocrinology reviews : PER

Growth hormone therapy in Turner syndrome.


PMID 22946284

Abstract

Short stature is the single most common physical abnormality in Turner syndrome (TS) with adult stature averaging 20 cm shorter than that of the general population. Randomized, placebo-controlled studies to final adult height have proven that GH therapy is effective in increasing stature in TS. Recently, randomized, controlled studies have demonstrated that adjunctive therapies with low-dose estrogen or low-dose oxandrolone enhance stature further. These therapies may provide benefits beyond height augmentation.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SML0437
Oxandrolone, ≥98% (HPLC)
C19H30O3